Trasylol-Aprotinin, an injectable drug used to stop bleeding for patients undergoing surgical procedures such like heart or kidney disease, was once praised as being a perfectly safe drug. However, additional studies and research proved otherwise causing the U.S. Food and Drug Administration (FDA) to warn doctors of the adverse side effects of the drug that include renal failure.